Goserelin depot versus danazol in the treatment of endometriosis the Australian/New Zealand experience

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 36, Issue 1, 1996, Pages 55-60

  Wingfield, Mary ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL; GOSERELIN; HORMONE RELEASE INHIBITING FACTOR; HYPOTHALAMUS RELEASING FACTOR;

ACNE; ADULT; AMNESIA; ANKLE EDEMA; ARTICLE; AUSTRALIA; CLINICAL TRIAL; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; HEADACHE; HIRSUTISM; HOT FLUSH; HUMAN; INFECTION; INSOMNIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MUSCLE CRAMP; NEW ZEALAND; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SUBCUTANEOUS DRUG ADMINISTRATION; XEROSIS;

EID: 13344269005     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.1996.tb02924.x     Document Type: Article

References (11)

1. Meldrum DR, Chang RJ, LU J, Vale W, Rivier J, Hudd HL. 'Medical oophorectomy' using a long-acting GnRH agonist - a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 1982; 54:1081-1083.
2. American Fertility Society. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril 1985; 43:351-352.
3. Fraser IS, Shearman RP, Jansen RPS, Sutherland PD. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol. Aust NZ J Obstet Gynecol 1991; 31:158-163.
4. Henzl MR, Corson SL, Moghissi K et al. Administration of nasal nafarelin as compared with oral danazol for endometriosis. NEJM 1988; 318:485-489.
5. The Nafarelin European Endometriosis Trial Group (NEET). Nafarelin for endometriosis; a large scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. Fertil Steril 1992; 57:514-522.
6. Shaw RW. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Fertil Steril 1992; 58:265-272.
7. Thomas EJ, Cooke ID. Impact of gestrinone on the course of asymptomatic endometriosis. BMJ 1987; 294:272-274.
8. Venturini PL, Fasce V, Constantini S et al. Treatment of endometriosis with goserelin depot, a long acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results. Fertil Steril 1990; 54:1021-1026.
9. Rock JA, Truglia JA, Caplan RJ and The Zoladex Endometriosis Study Group. Zoladex (Goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. Obstet Gynecol 1993; 82:198-205.
10. Wingfield M and Healy DL. Endometriosis: medical therapy. In: Brosens I (ed). Endometriosis, Bailliere's Clinical Obstetrics and Gynaecology 1993; 7:4, 813-838.
11. Barbieri RL. Hormone treatment of endometriosis: The estrogen threshold hypothesis. Am J Obstet Gynecol 1992; 166:740-745.